Hepatic encephalopathy is a brain dysfunction with neurological and psychiatric changes associated with liver failure or portal-systemic shunting.. Severity ranges from minor symptoms to coma.
A Cochrane systematic review including 11 randomized clinical trials on branched-chain amino acids (BCAA) versus control interventions assessed whether BCAAs can benefit people with hepatic encephalopathy.
Read more (English)
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.